Φορτώνει......
What the Clinical Microbiologist Should Know About PK/PD in the Era of Emerging Multidrug-Resistance: Beta-Lactam/Beta-Lactamase Inhibitor Combinations
As a class, β-lactamase inhibitors have proven successful in extending the clinical utility of β-lactam antibiotics by circumventing β-lactamase-mediated resistance. However, the rapid evolution of these β-lactamases calls for a critical re-evaluation of the relationships between susceptibility, dru...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Lab Med |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686870/ https://ncbi.nlm.nih.gov/pubmed/31383269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cll.2019.05.006 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|